Inactive Instrument

News Shengtai Pharmaceutical, Inc. Other OTC

Equities

Qingtai Liu, Chairman and Chief Executive Officer of Shengtai Pharmaceutical Inc. cancelled the acquisition of the remaining 59.5% stake in Shengtai Pharmaceutical Inc. from Pope Investments LLC, a fund of Pope Asset Management, LLC and other investors.	24/07/13	CI
Shengtai Pharmaceutical Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2013	16/05/13	CI
Shengtai Pharmaceutical Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2012	15/02/13	CI
Shengtai Pharmaceutical Inc. Announces Unaudited Consolidated Financial Results for the First Quarter Ended September 30, 2012	15/11/12	CI
Shengtai Pharmaceutical Inc. Announces Consolidated Earnings Results for the Year Ended June 30, 2012	28/09/12	CI
Shengtai Pharmaceutical Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2012	16/05/12	CI
Qingtai Liu, Chairman and Chief Executive Officer of Shengtai Pharmaceutical Inc. made an offer to acquire remaining 59.5% stake in Shengtai Pharmaceutical Inc. from Pope Investments LLC, a fund of Pope Asset Management, LLC and other investors for $9.4 million.	17/04/12	CI
Shengtai Pharmaceutical Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2011	15/02/12	CI

No results for this search